We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$225B
1-Year Est. Return
49.49%
This Fund
S&P 500
This Quarter
Est. Return
+11.74%
1 Year Est. Return
+49.49%
3 Year Est. Return
+172.58%
5 Year Est. Return
+223.9%
10 Year Est. Return
+876%
AUM
$71.5B
AUM Growth
+$3.66B
(+5.4%)
Cap. Flow
-$2.85B
Cap. Flow
% of AUM
-3.99%
Top 10 Holdings %
Top 10 Hldgs %
18.22%
Holding
1,538
New
294
Increased
526
Reduced
448
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$268M |
| 2 |
General Motors
GM
|
+$263M |
| 3 |
AstraZeneca
AZN
|
+$235M |
| 4 |
Vale
VALE
|
+$226M |
| 5 |
Oracle
ORCL
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$945M |
| 2 |
Microsoft
MSFT
|
+$606M |
| 3 |
Canadian Natural Resources
CNQ
|
+$552M |
| 4 |
Bank of America
BAC
|
+$490M |
| 5 |
AbbVie
ABBV
|
+$432M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.7% |
| 2 | Healthcare | 20.13% |
| 3 | Consumer Discretionary | 15.62% |
| 4 | Financials | 9.5% |
| 5 | Energy | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Regional Management Corp
RM
$301M
| $1.26M | ﹤0.01% |
44,818
-3,607
| -7% | -$106K |
|
977
Allison Transmission
ALSN
$10.2B
| $1.25M | ﹤0.01% |
+30,139
| New | +$1.24M |
|
978
Ituran Location and Control
ITRN
$1.06B
| $1.25M | ﹤0.01% |
59,307
+37,826
| +176% | +$863K |
|
979
CACI
CACI
$14.8B
| $1.25M | ﹤0.01% |
4,161
-7,857
| -65% | -$2.29M |
|
|
CEPU
980
Central Puerto
CEPU
$1.99B
| $1.25M | ﹤0.01% |
+210,623
| New | +$1.04M |
|
981
OceanFirst Financial
OCFC
$1.88B
| $1.25M | ﹤0.01% |
58,870
-134,297
| -70% | -$2.93M |
|
982
Titan Machinery
TITN
$420M
| $1.24M | ﹤0.01% |
31,174
+2,975
| +11% | +$106K |
|
983
Tactile Systems Technology
TCMD
$537M
| $1.23M | ﹤0.01% |
+107,512
| New | +$946K |
|
984
Yext
YEXT
$613M
| $1.21M | ﹤0.01% |
+184,782
| New | +$1.01M |
|
985
Fortis
FTS
$28.8B
| $1.2M | ﹤0.01% |
30,009
-106,612
| -78% | -$4.18M |
|
986
Pearson
PSO
$9.78B
| $1.2M | ﹤0.01% |
+106,375
| New | +$1.17M |
|
987
Regeneron Pharmaceuticals
REGN
$83B
| $1.2M | ﹤0.01% |
1,661
+656
| +65% | +$484K |
|
988
Universal Electronics
UEIC
$66.6M
| $1.19M | ﹤0.01% |
+57,122
| New | +$1.18M |
|
989
V2X
VVX
$2.55B
| $1.19M | ﹤0.01% |
28,709
+5,411
| +23% | +$215K |
|
990
WisdomTree India Earnings Fund ETF
EPI
$2.04B
| $1.18M | ﹤0.01% |
36,267
-19,695
| -35% | -$638K |
|
|
PDCO
991
DELISTED
Patterson Companies, Inc.
PDCO
| $1.17M | ﹤0.01% |
41,618
+12,462
| +43% | +$344K |
|
992
Consolidated Edison
ED
$40.1B
| $1.17M | ﹤0.01% |
+12,223
| New | +$1.11M |
|
|
RYZ
993
Ryerson Holding Corp
RYZ
$1.5B
| $1.17M | ﹤0.01% |
+38,486
| New | +$1.14M |
|
|
CRESY
994
Cresud
CRESY
$752M
| $1.16M | ﹤0.01% |
180,487
+23,267
| +15% | +$125K |
|
995
Lands' End
LE
$390M
| $1.16M | ﹤0.01% |
152,303
-17,976
| -11% | -$165K |
|
996
Pfizer
PFE
$153B
| $1.15M | ﹤0.01% |
22,531
-122,027
| -84% | -$5.85M |
|
997
WIX.com
WIX
$3.35B
| $1.14M | ﹤0.01% |
+14,834
| New | +$1.2M |
|
|
CAMP
998
DELISTED
CalAmp Corp.
CAMP
| $1.14M | ﹤0.01% |
11,054
-269
| -2% | -$22.7K |
|
|
ASRT
999
DELISTED
Assertio
ASRT
| $1.1M | ﹤0.01% |
+17,034
| New | +$749K |
|
|
API
1000
Agora
API
$408M
| $1.09M | ﹤0.01% |
+279,997
| New | +$924K |
|
Similar funds
Arrowstreet Capital's Q4 2022 Portfolio in Review
As of Q4 2022, Arrowstreet Capital held 1,538 positions worth $71.5B, up 5.4% from $67.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $2.85B in Q4 2022, closing 234 positions and reducing 448 holdings. Its most notable exit was AbbVie, an estimated $432M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Gerdau worth $105M.
- Arrowstreet Capital's largest Q4 2022 buy was Gerdau: 23,855,591 shares worth $105M.
- Arrowstreet Capital added most to Visa in Q4 2022, an estimated $268M increase.
- Arrowstreet Capital's biggest Q4 2022 reduction was JPMorgan Chase, cutting an estimated $945M.
- Arrowstreet Capital fully exited AbbVie in Q4 2022, selling an estimated $432M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $71.5B portfolio in Q4 2022.
- Arrowstreet Capital opened 294 new positions and closed 234 in Q4 2022.
- Arrowstreet Capital's portfolio value rose 5.4% quarter-over-quarter to $71.5B.
Based on Arrowstreet Capital's 13F filing for Q4 2022, filed 14 Feb 2023.